Healthcare provider profile · identity verified

Cindy Loh, MD

Family Practice · MORENO VALLEY, CA · NPI 1942507983

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	272	89
Atorvastatin Calcium	Atorvastatin Calcium	254	100
Levothyroxine Sodium	Levothyroxine Sodium	201	69
Hydrochlorothiazide	Hydrochlorothiazide	193	67
Gabapentin	Gabapentin	158	57
Lisinopril	Lisinopril	155	64
Alvesco	Ciclesonide	113	55
Amlodipine Besylate	Amlodipine Besylate	103	39
Sertraline Hcl	Sertraline Hcl	90	25
Albuterol Sulfate Hfa	Albuterol Sulfate	86	47
Ibuprofen	Ibuprofen	85	45
Trazodone Hcl	Trazodone Hcl	83	32
Metformin Hcl Er	Metformin Hcl	74	34
Famotidine	Famotidine	71	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	19
Fluticasone Propionate	Fluticasone Propionate	65	26
Metoprolol Succinate	Metoprolol Succinate	55	22
Metoprolol Tartrate	Metoprolol Tartrate	53	24
Jardiance	Empagliflozin	51	21
Furosemide	Furosemide	44	28
Ozempic	Semaglutide	44	suppressed
Propranolol Hcl	Propranolol Hcl	44	18
Tamsulosin Hcl	Tamsulosin Hcl	43	18
Atenolol	Atenolol	42	16
Omeprazole	Omeprazole	41	17
Simvastatin	Simvastatin	41	18
Chlorthalidone	Chlorthalidone	39	15
Montelukast Sodium	Montelukast Sodium	39	17
Pantoprazole Sodium	Pantoprazole Sodium	39	17
Alendronate Sodium	Alendronate Sodium	36	13
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Metformin Hcl	Metformin Hcl	34	16
Acetaminophen-Codeine	Acetaminophen With Codeine	33	12
Allopurinol	Allopurinol	33	suppressed
Meloxicam	Meloxicam	33	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Prednisone	Prednisone	32	29
Carvedilol	Carvedilol	29	11
Lovastatin	Lovastatin	29	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	29	suppressed
Potassium Chloride	Potassium Chloride	28	13
Azelastine Hcl	Azelastine Hcl	27	suppressed
Breyna	Budesonide/Formoterol Fumarate	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Eliquis	Apixaban	25	suppressed
Glipizide	Glipizide	25	11
Ipratropium Bromide	Ipratropium Bromide	25	12
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	21	21
Cefadroxil	Cefadroxil	21	19
Doxycycline Monohydrate	Doxycycline Monohydrate	21	17
Ondansetron Odt	Ondansetron	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	14
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	14
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Glipizide Er	Glipizide	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Trospium Chloride	Trospium Chloride	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Terazosin Hcl	Terazosin Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Mupirocin	Mupirocin	13	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Naproxen	Naproxen	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error